Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100,000
Closed -$4.39M 5990
2024
Q4
$4.39M Buy
100,000
+80,000
+400% +$3.51M ﹤0.01% 2931
2024
Q3
$861K Buy
+20,000
New +$891K ﹤0.01% 4396
2024
Q2
Sell
-30,200
Closed -$1.89M 6040
2024
Q1
$1.89M Buy
30,200
+9,800
+48% +$586K ﹤0.01% 3795
2023
Q4
$1.14M Buy
+20,400
New +$1.02M ﹤0.01% 4054
2019
Q4
Sell
-41,077
Closed -$2.05M 4312
2019
Q3
$2.05M Buy
+41,077
New +$1.94M ﹤0.01% 2426
2015
Q2
Sell
-3,777
Closed -$310K 3448
2015
Q1
$310K Buy
+3,777
New +$316K ﹤0.01% 3018

Other funds holding ENOV

Israel Englander's ENOV Position: Q2 2026 in Review

Israel Englander increased its Enovis (ENOV) stake by 28% in Q2 2026, buying an estimated $4.1M and bringing the position to 803,315 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #1797.

Israel Englander first reported a position in ENOV in Q2 2013 and has held it in 49 quarters since. The position peaked at $137M in Q1 2024. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Israel Englander held 803,315 shares of Enovis worth $16.6M as of Q2 2026.
  • Israel Englander bought 173,999 Enovis shares in Q2 2026, an estimated $4.1M.
  • Enovis made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1797 holding.
  • Israel Englander first reported a position in Enovis in Q2 2013 and has held it in 49 quarters since.
  • Israel Englander's Enovis position peaked at $137M in Q1 2024.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.